- β-Amyloid and tau biomarkers and clinical phenotype in dementia with Lewy bodies2020 | Second Faculty of Medicine
- Determination of tau proteins and beta-amyloic 42 in cerebrospinal fluid by ELISA methods and preliminary normative values2019 | First Faculty of Medicine, Third Faculty of Medicine, Central Library of Charles University
- New pharmacological options in the treatment of Alzheimer's disease2022 | Second Faculty of Medicine, Faculty of Physical Education and Sport
- Overview of Immunoanalytical Methods for Determination of Alzheimer's Disease Biomarkers' Triplet in Cerebrospinal Fluid and Blood2020 | First Faculty of Medicine, Third Faculty of Medicine
- Sporadic Creutzfeldt-Jakob Disease and Other Proteinopathies in Comorbidity2020 | First Faculty of Medicine, Third Faculty of Medicine
- The Role of Lipid Environment in Ganglioside GM1-Induced Amyloid beta Aggregation2020 | Faculty of Science
- From diagnosis of depression, generalized - anxiety disorder, schizoaffective disorder to diagnose of microtubule--associated protein tau mutation (MAPT) S305N presenile dementia, weaknesses of phenomenological classification2022 | Third Faculty of Medicine
- Research of new drugs for Alzheimer's disease2017 | First Faculty of Medicine
- Cognitive superagers2020 | Publication without faculty affiliation
- Validation of the LUMIPULSE automated immunoassay for the measurement of core AD biomarkers in cerebrospinal fluid2022 | Second Faculty of Medicine
- Design, synthesis, and biological evaluation of 1-benzylamino-2-hydroxyalkyl derivatives as new potential disease-modifying multifunctional anti-Alzheimer's agents2018 | Publication without faculty affiliation
- Beauveriolide I (beauverolide I), 98 %Publication without faculty affiliation
- Beauveriolide F (beauverolide F), >98 %Publication without faculty affiliation
- Beauveriolide M (beauverolide M), >98 %Publication without faculty affiliation
- MRI data-driven clustering reveals different subtypes of Dementia with Lewy bodies2023 | Second Faculty of Medicine
- Cerebrospinal fluid and blood serum biomarkers in neurodegenerative proteinopathies: A prospective, open, cross-correlation study2023 | Third Faculty of Medicine